OralDosed ingredientTherapeutic flag Cosmetic cross-reference

Lactitol

CAS 585-86-4

Lactitol (CAS 585-86-4) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 2 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
2
SOURCE DrugCentral
Adverse signals
2
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Lactitol
CAS Number
585-86-4
UNII
L2B0WJF7ZY
InChIKey
VQHSOMBJVWLPSR-JVCRWLNRSA-N
ChEMBL ID
CHEMBL1661
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientnatural productoraltherapeutic flag
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1661 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 28748.519444444442 nM 72 -
- IC50 19976.309999999998 nM 1 -
SOURCE DrugCentral 1 association

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Hepatic encephalopathy 27 99.1 10019660

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
LACTITOL 28395 SU MTHSPL
lactitol 28395 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Lactitol used for in pharmaceutical contexts?

Lactitol (CAS 585-86-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Lactitol?

Lactitol has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Hepatic encephalopathy, Mixed liver injury. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Lactitol also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Lactitol with EU status "permitted".

What clinical phase is Lactitol in?

Lactitol is rendered with ChEMBL max phase 4 (approved).